Boody Barrett S, Smucker Joseph D, Sasso Willa, Miller Justin W, Snowden Ryan, Sasso Rick C
Indiana Spine Group, 13225 N. Meridian St, Carmel, IN, 46032, USA.
Indiana University, 107 S Indiana Ave, Bloomington, IN, 47405, USA.
J Orthop. 2020 Mar 27;21:171-177. doi: 10.1016/j.jor.2020.03.025. eCollection 2020 Sep-Oct.
To determine the efficacy of DIAM Spinal Stabilization System compared with nonoperative treatment for patients with low back pain and lower lumbar disc degenerative disease.
A single center collected prospective outcomes data on 38 patients randomized to an interspinous device or non-operative treatment for symptomatic lumbar degenerative disc disease with treatment crossover allowed at 6 months.
At all postoperative timepoints out to 2-years, statistically significant improvements in ODI and back pain scores were observed with the interspinous device. Clinically significant improvements (ODI >15-point improvement) were seen in 87.5% of DIAM patients at 2-years postoperatively. A high cross-over rate was noted from the non-operative cohort to the operative group (12 of 15) due to continued pain with nonoperative care. Additionally, 80% of patients receiving the DIAM implant reported a >15-point ODI reduction from pre-surgical scores at 2-year follow-up.
The DIAM device demonstrates improvement in ODI and Back Pain scores maintained out to a 2-year follow-up timepoint and performed superior to conventional nonoperative treatment regimens commonly used in low back pain.
确定DIAM脊柱稳定系统与非手术治疗相比,对下腰痛和下腰椎间盘退变疾病患者的疗效。
一个单中心收集了38例患者的前瞻性结果数据,这些患者被随机分配接受棘突间装置治疗或非手术治疗,用于有症状的腰椎间盘退变疾病,允许在6个月时进行治疗交叉。
在术后长达2年的所有时间点,使用棘突间装置观察到ODI(腰椎功能障碍指数)和背痛评分有统计学意义的改善。术后2年,87.5%的DIAM患者出现了具有临床意义的改善(ODI改善>15分)。由于非手术治疗持续疼痛,从非手术队列到手术组的交叉率很高(15例中有12例)。此外,在2年随访时,80%接受DIAM植入的患者报告ODI较术前评分降低>15分。
DIAM装置在长达2年的随访时间点显示出ODI和背痛评分的改善,并且表现优于常用于下腰痛的传统非手术治疗方案。